Ethnic disparities and its association between epicardial adipose tissue thickness and cardiometabolic parameters

References

• AlZaim I, Hammoud SH, Al-Koussa H, et al. Adipose tissue immunomodulation: a novel therapeutic approach in cardiovascular and metabolic diseases. Front Cardiovasc Med. 2020;7:602088.
   PubMed Web of Science ®Google Scholar
• Bertaso AG, Bertol D, Duncan BB, et al. Epicardial fat: definition, measurements and systematic review of main outcomes. Arq Bras Cardiol. 2013;101(1). doi: 10.5935/abc.20130138
   PubMed Web of Science ®Google Scholar
• Sacks HS, Fain JN, Bahouth SW, et al. Human epicardial fat exhibits beige features. J Clin Endocrinol Metab. 2013;98(9):E1448–9. doi: 10.1210/jc.2013-1265
   PubMed Web of Science ®Google Scholar
• Chen HJ, Meng T, Gao PJ, et al. The role of brown adipose tissue dysfunction in the development of cardiovascular disease. Front Endocrinol (Lausanne). 2021;12:652246. doi: 10.3389/fendo.2021.652246
   PubMed Web of Science ®Google Scholar
• Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022;19(9):593–606.
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhang A, Hamilton D, et al. Epicardial Fat in the Maintenance of Cardiovascular Health. Methodist Debakey Cardiovasc J. 2017;13(1):20. doi: 10.14797/mdcj-13-1-20
   PubMedGoogle Scholar
• Iacobellis G, Malavazos AE, Corsi MM. Epicardial fat: from the biomolecular aspects to the clinical practice. Int J Biochem Cell Biol. 2011;43(12):1651–1654. doi: 10.1016/j.biocel.2011.09.006
   PubMed Web of Science ®Google Scholar
• Talman AH, Psaltis PJ, Cameron JD, et al. Epicardial adipose tissue: far more than a fat depot. Cardiovasc Diagn Ther. 2014;4(6):416. doi: 10.3978/j.issn.2223-3652.2014.11.05
   PubMedGoogle Scholar
• Staiano AE, Broyles ST, Gupta AK, et al. Ethnic and sex differences in visceral, subcutaneous, and total body fat in children and adolescents. Obesity. 2013;21(6):1251–1255. doi: 10.1002/oby.20210
   PubMed Web of Science ®Google Scholar
• Tscharre M, Hauser C, Rohla M, et al. Epicardial adipose tissue and cardiovascular outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Hear Journal Acute Cardiovasc Care. 2017;6(8):750–752. doi: 10.1177/2048872616680609
   PubMed Web of Science ®Google Scholar
• Salami SS, Tucciarone M, Bess R, et al. Race and epicardial fat: the impact of anthropometric measurements, percent body fat and sex. Ethn Dis. 2013;23(3):281–285.
   PubMed Web of Science ®Google Scholar
• Toufan M, Azarfarin R, Sadati B, et al. The association between epicardial adipose tissue and coronary artery disease: an echocardiographic cut-off point. J Cardiovasc Thorac Res. 2012;4(2):31–316. doi: 10.5681/jcvtr.2012.008
   PubMedGoogle Scholar
• Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet. 2005;366(9491):1059–1062. doi: 10.1016/S0140-6736(05)67402-8
   PubMed Web of Science ®Google Scholar
• Hirata Y, Yamada H, Kusunose K, et al. Clinical utility of measuring epicardial adipose tissue thickness with echocardiography using a high-frequency linear probe in patients with coronary artery disease. J Am Soc Echocardiogr. 2015;28(10):1240–1246.e1. doi: 10.1016/j.echo.2015.07.006
   PubMed Web of Science ®Google Scholar
• Yagi S, Hirata Y, Ise T, et al. Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus. Diabetol Metab Syndr. 2017;9(1). doi: 10.1186/s13098-017-0275-4
   PubMedGoogle Scholar
• Kim MK, Kim B, Lee JY, et al. Tissue doppler-derived e/e′ ratio as a parameter for assessing diastolic heart failure and as a predictor of mortality in patients with chronic kidney disease. Korean J Intern Med. 2013;28(1):35–44. doi: 10.3904/kjim.2013.28.1.35
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79–108. doi: 10.1016/j.euje.2005.12.014
   PubMed Web of Science ®Google Scholar
• Villasante Fricke AC, Iacobellis G. Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk. Int J Mol Sci. 2019;20(23):1–13. doi: 10.3390/ijms20235989
   Web of Science ®Google Scholar
• Wang CP, Hsu HL, Hung WC, et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus an association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol. 2009;70(6):876–882. doi:10.1111/j.1365-2265.2008.03411.x
   PubMed Web of Science ®Google Scholar
• Nazare JA, Smith JD, Borel AL, et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the international study of prediction of intra-abdominal adiposity and its relationship with cardiometabolic risk/intra-. Am J Clin Nutr. 2012;96(4):714–726. doi: 10.3945/ajcn.112.035758
   PubMed Web of Science ®Google Scholar
• Verma B, Katyal D, Patel A, et al. Relation of systolic and diastolic epicardial adipose tissue thickness with presence and severity of coronary artery disease (the EAT CAD study). J Fam Med Prim Care. 2017;6(2):169–170.
   PubMedGoogle Scholar
• Park JS, Lee YH, Seo KW, et al. Echocardiographic epicardial fat thickness is a predictor for target vessel revascularization in patients with ST-elevation myocardial infarction. Lipids Health Dis. 2016;15(1):1–7. doi: 10.1186/s12944-016-0371-8
   PubMedGoogle Scholar
• Fukuda T, Bouchi R, Terashima M, et al. Ipragliflozin reduces epicardial fat accumulation in non-obese type 2 diabetic patients with visceral obesity: a pilot study. Diabetes Ther. 2017;8(4):851–861. doi: 10.1007/s13300-017-0279-y
   PubMed Web of Science ®Google Scholar
• Bouchi R, Terashima M, Sasahara Y, et al. Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: A pilot study. Cardiovasc Diabetol. 2017;16(1). doi: 10.1186/s12933-017-0516-8
   PubMedGoogle Scholar
• Jin X, Hung CL, Tay WT, et al. Epicardial adipose tissue related to left atrial and ventricular function in heart failure with preserved versus reduced and mildly reduced ejection fraction. Eur J Heart Fail. 2022;24(8):1346–1356. doi: 10.1002/ejhf.2513
   PubMed Web of Science ®Google Scholar
• Alkatiri AH, Bakri S, Patellongi I, et al. The relationship between epicardial adipose tissue thickness with severity of coronary artery disease in Indonesia. Int J Sci Basic Appl Res. 2016;30(5):244–253.
   Google Scholar
• Rim R, Viveiros A, Oudit GY, et al. Targeting perivascular and epicardial adipose tissue inflammation: therapeutic opportunities for cardiovascular disease. Clin Sci. 2020;134(7):827–851. doi: 10.1042/CS20190227
   Web of Science ®Google Scholar
• Park JH, Park YS, Kim YJ, et al. Effects of statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: comparison of atorvastatin with simvastatin/ezetimibe. J Cardiovasc Ultrasound. 2010;18(4):121. doi: 10.4250/jcu.2010.18.4.121
   PubMedGoogle Scholar
• Meenakshi K, Rajendran M, Srikumar S, et al. Epicardial fat thickness: a surrogate marker of coronary artery disease - assessment by echocardiography. Indian Heart J. 2016;68(3):336–341. doi: 10.1016/j.ihj.2015.08.005
   PubMedGoogle Scholar
• Aprigliano G, Scuteri L, Iafelice I, et al. Epicardial adipose tissue thickness and acute coronary syndrome: a matter of how much or how? Int J Cardiol. 2015;199:8–9. doi: 10.1016/j.ijcard.2015.06.168
   PubMed Web of Science ®Google Scholar
• Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr. 2009;22(12):1311–1319. doi: 10.1016/j.echo.2009.10.013
   PubMed Web of Science ®Google Scholar
• Adams DB, Narayan O, Munnur RK, et al. Ethnic differences in coronary plaque and epicardial fat volume quantified using computed tomography. Int J Cardiovasc Imaging. 2017;33(2):241–249. doi: 10.1007/s10554-016-0982-1
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Pierdomenico AM, Cuccurullo F, et al. Meta-analysis of the relation of echocardiographic epicardial adipose tissue thickness and the metabolic syndrome. Am J Cardiol. 2013;111(1):73–78. doi: 10.1016/j.amjcard.2012.08.044
   PubMed Web of Science ®Google Scholar
• Chee KH, Tan KL, Luqman I, et al. Prevalence and predictors of left ventricular diastolic dysfunction in Malaysian patients with type 2 diabetes mellitus without prior known cardiovascular disease. Front Cardiovasc Med. 2021;8(September):8–15. doi: 10.3389/fcvm.2021.676862
   Google Scholar
• Eren H, Omar MB, Ü K, et al. Epicardial fat tissue can predict subclinical left ventricular dysfunction in patients with erectile dysfunction. Aging Male. 2021;24(1):42–49. doi: 10.1080/13685538.2021.1945572
   PubMed Web of Science ®Google Scholar
• Qian C, Sun Y, Jiang J. Diagnostic values of epicardial adipose tissue thickness with right common carotid artery elasticity and intima-media thickness for middle-aged and elderly patients with coronary heart disease. Int J Gen Med. 2021;14:633–639. doi: 10.2147/IJGM.S292426
   PubMed Web of Science ®Google Scholar
• Kuk JL, Saunders TJ, Davidson LE, et al. Age-related changes in total and regional fat distribution. Ageing Res Rev. 2009;8(4):339–348. doi: 10.1016/j.arr.2009.06.001
   PubMed Web of Science ®Google Scholar
• Lima-Martínez MM, Campo E, Salazar J, et al. Epicardial fat thickness as cardiovascular risk factor and therapeutic target in patients with rheumatoid arthritis treated with biological and nonbiological therapies. Arthritis. 2014;2014:1–7. doi: 10.1155/2014/782850.
   Google Scholar